Correlation Between Icosavax and Leap Therapeutics
Can any of the company-specific risk be diversified away by investing in both Icosavax and Leap Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Leap Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icosavax and Leap Therapeutics, you can compare the effects of market volatilities on Icosavax and Leap Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Leap Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Leap Therapeutics.
Diversification Opportunities for Icosavax and Leap Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Icosavax and Leap is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Leap Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Leap Therapeutics and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Leap Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Leap Therapeutics has no effect on the direction of Icosavax i.e., Icosavax and Leap Therapeutics go up and down completely randomly.
Pair Corralation between Icosavax and Leap Therapeutics
If you would invest (100.00) in Icosavax on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Icosavax or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Icosavax vs. Leap Therapeutics
Performance |
Timeline |
Icosavax |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Leap Therapeutics |
Icosavax and Leap Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Icosavax and Leap Therapeutics
The main advantage of trading using opposite Icosavax and Leap Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Leap Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Leap Therapeutics will offset losses from the drop in Leap Therapeutics' long position.Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Fundamental Analysis View fundamental data based on most recent published financial statements |